![Newron Pharmaceuticals S.p.A. logo](/logos/NWRN.SW.webp)
Newron Pharmaceuticals S.p.A.
SIX:NWRN.SW
Overview | Financials
Company Name | Newron Pharmaceuticals S.p.A. |
Symbol | NWRN.SW |
Currency | CHF |
Price | 8 |
Market Cap | 152,471,200 |
Dividend Yield | 0% |
52-week-range | 4.09 - 11.2 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Stefan Weber |
Website | https://www.newron.com |
An error occurred while fetching data.
About Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD